The FDA expanded the indication of teduglutide (Gattex, Takeda) for injection to include pediatric patients 1 year of age and older with short bowel syndrome (SBS) who require parenteral nutrition or fluid support.
“As a pediatric gastroenterologist, one of my main treatment goals for children with SBS is to reduce their dependency on parenteral support,” said Beth Carter, MD, the medical director of intestinal rehabilitation and nutrition support at Children’s Hospital Los